tirzepatide and claritin Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review The catcher in the gut:

Most patients report reduced food cravings and improved portion control within 24 weeks of starting therapy

Still, others are wary of moving forward with so little data on its safety

That said, its crucial to consult a healthcare provider to determine if this treatment aligns with your needs and to set realistic expectations for the results

Its weight-loss results tend to be more modest compared to Wegovy or Zepbound, making it a good option for people who either cannot tolerate semaglutide/tirzepatide or prefer the control of daily dosing

When appetite drops hard, it is easy to under eat protein without noticing, and that is the fast track to losing muscle along with fat